MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia

Abstract Background MicroRNAs are of special interest in cancer research and hold significant promise as diagnostic and prognostic biomarkers for malignant disease. MiR-362-5p have been found to exert both oncogenic and tumor suppressive effects depending highly on the cellular context. The aim of t...

Full description

Bibliographic Details
Main Authors: Qiu-Ling Ma, Jing-Han Wang, Min Yang, Huan-ping Wang, Jie Jin
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Journal of Translational Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12967-018-1445-3
_version_ 1811204747701518336
author Qiu-Ling Ma
Jing-Han Wang
Min Yang
Huan-ping Wang
Jie Jin
author_facet Qiu-Ling Ma
Jing-Han Wang
Min Yang
Huan-ping Wang
Jie Jin
author_sort Qiu-Ling Ma
collection DOAJ
description Abstract Background MicroRNAs are of special interest in cancer research and hold significant promise as diagnostic and prognostic biomarkers for malignant disease. MiR-362-5p have been found to exert both oncogenic and tumor suppressive effects depending highly on the cellular context. The aim of this study was to determine whether the expression of miR-362-5p can be served as a prognostic factor for patients with cytogentically normal acute myeloid leukemia (CN-AML). Methods We enrolled 224 patients with CN-AML and measured the expression of miR-362-5p by quantitative real time PCR analysis. We classified patients into high and low expression based on the median value. The Cox regression analyses were carried out to assess the prognostic significance of miR-362-5p expression in the context of the well-established predictors. Additionally, microRNA expression profiling were conducted to identify the biological insights between high and low group. Results High expressers had older age. High expressers obtained shorter overall survival in the univariate analysis. The independent prognostic value of miR-362-5p remained in the context of the well-established clinical and cytogenetic predictors. Moreover, the prognostic value of miR-362-5p was also validated in an independent cohort of CN-AML. Notably, numerous oncomiRs were also high expressed in high miR-362-5p group. Conclusion High miR-362-5p expression was associated with poorer overall survival implicating the oncogenic function in AML development.
first_indexed 2024-04-12T03:18:55Z
format Article
id doaj.art-b81c98796ad649749d83611ed8748181
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-04-12T03:18:55Z
publishDate 2018-03-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-b81c98796ad649749d83611ed87481812022-12-22T03:49:59ZengBMCJournal of Translational Medicine1479-58762018-03-011611610.1186/s12967-018-1445-3MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemiaQiu-Ling Ma0Jing-Han Wang1Min Yang2Huan-ping Wang3Jie Jin4Department of Hematology, The First Affiliated Hospital, Zhejiang University of MedicineDepartment of Hematology, The First Affiliated Hospital, Zhejiang University of MedicineDepartment of Hematology, The First Affiliated Hospital, Zhejiang University of MedicineKey Laboratory of Hematopoietic MalignanciesDepartment of Hematology, The First Affiliated Hospital, Zhejiang University of MedicineAbstract Background MicroRNAs are of special interest in cancer research and hold significant promise as diagnostic and prognostic biomarkers for malignant disease. MiR-362-5p have been found to exert both oncogenic and tumor suppressive effects depending highly on the cellular context. The aim of this study was to determine whether the expression of miR-362-5p can be served as a prognostic factor for patients with cytogentically normal acute myeloid leukemia (CN-AML). Methods We enrolled 224 patients with CN-AML and measured the expression of miR-362-5p by quantitative real time PCR analysis. We classified patients into high and low expression based on the median value. The Cox regression analyses were carried out to assess the prognostic significance of miR-362-5p expression in the context of the well-established predictors. Additionally, microRNA expression profiling were conducted to identify the biological insights between high and low group. Results High expressers had older age. High expressers obtained shorter overall survival in the univariate analysis. The independent prognostic value of miR-362-5p remained in the context of the well-established clinical and cytogenetic predictors. Moreover, the prognostic value of miR-362-5p was also validated in an independent cohort of CN-AML. Notably, numerous oncomiRs were also high expressed in high miR-362-5p group. Conclusion High miR-362-5p expression was associated with poorer overall survival implicating the oncogenic function in AML development.http://link.springer.com/article/10.1186/s12967-018-1445-3miR-362-5pAcute myeloid leukemiaGene expressionPrognosis
spellingShingle Qiu-Ling Ma
Jing-Han Wang
Min Yang
Huan-ping Wang
Jie Jin
MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia
Journal of Translational Medicine
miR-362-5p
Acute myeloid leukemia
Gene expression
Prognosis
title MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia
title_full MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia
title_fullStr MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia
title_full_unstemmed MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia
title_short MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia
title_sort mir 362 5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia
topic miR-362-5p
Acute myeloid leukemia
Gene expression
Prognosis
url http://link.springer.com/article/10.1186/s12967-018-1445-3
work_keys_str_mv AT qiulingma mir3625pasanovelprognosticpredictorofcytogeneticallynormalacutemyeloidleukemia
AT jinghanwang mir3625pasanovelprognosticpredictorofcytogeneticallynormalacutemyeloidleukemia
AT minyang mir3625pasanovelprognosticpredictorofcytogeneticallynormalacutemyeloidleukemia
AT huanpingwang mir3625pasanovelprognosticpredictorofcytogeneticallynormalacutemyeloidleukemia
AT jiejin mir3625pasanovelprognosticpredictorofcytogeneticallynormalacutemyeloidleukemia